A Plus Biotechnology Co., Ltd. (TPE:6918)

Market Cap	2.47B -24.6%
Revenue (ttm)	858.89M +9.0%
Net Income	173.26M +9.1%
EPS	5.13 -1.6%
Shares Out	33.70M
PE Ratio	14.30
Forward PE	n/a
Dividend	5.00 (6.82%)
Ex-Dividend Date	Mar 27, 2026

Volume	28,474
Open	73.00
Previous Close	73.10
Day's Range	72.90 - 74.80
52-Week Range	72.40 - 136.00
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About A Plus Biotechnology

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6918

Financial Performance

In 2025, A Plus Biotechnology's revenue was 835.89 million, an increase of 8.61% compared to the previous year's 769.59 million. Earnings were 169.38 million, an increase of 12.13%.